BRIDGEWATER, NJ / ACCESSWIRE / October 30, 2024 / Tharimmune, Inc. (NASDAQ:THAR) ('Tharimmune' or the 'Company'), a clinical-stage biotechnology ...

Nighttime itch can be annoying and even worrying. Here, 5 possible reasons you're itchy at night, as well as ...

TH104, the Company's lead candidate for moderate-to-severe pruritus in chronic liver disease, showed no opioid withdrawal ...

Tharimmune, Inc. (NASDAQ:THAR) shares are moving higher on Wednesday after the company announced it received overall positive ...

known as pruritus. This can potentially prevent an accurate and prompt diagnosis. PBC affects approximately nine women for ...

New research reveals itchiness may be a defense mechanism, with persistent pruritus serving as the skin’s early alarm against ...

The following is a summary of “Assessing disease control in patients with atopic dermatitis by using the atopic dermatitis ...

The ADapt study assessed the efficacy and safety of EBGLYSS in individuals who had previously been treated with dupilumab.

A collaborative study has revealed how a specific species of mammal-targeting worms found a way around itch, allowing researchers to better understand the mammalian urge to scratch.

A wide range of conditions can cause an itchy neck—such as eczema, psoriasis, and diabetes. This itchiness is medically also known as pruritus. An itchy neck usually isn’t a sign of anything serious ...

The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2024 October 23–27.